RiverRun International Film Festival

“Outside Line” to Premier at DC/DOX Film Festival

Retrieved on: 
Wednesday, June 7, 2023

The film, which was produced by Events DC staff at GATHER by Events DC, will be on the slate for DC/FRAME, a special festival program curated in partnership with HumanitiesDC.

Key Points: 
  • The film, which was produced by Events DC staff at GATHER by Events DC, will be on the slate for DC/FRAME, a special festival program curated in partnership with HumanitiesDC.
  • The film, directed by Jack Gordon and executive produced by Emma Barcklow, was nominated in the Sports Story—Long Form Content category.
  • I hope all enjoy the film!”
    The inaugural DC/DOX festival will be held June 15-18, 2023 in Washington, DC.
  • Since then, the film has screened at notable film festivals across the United States, including the Academy Award-qualifying Pan-African Film Festival, American Documentary & Animation Film Festival and RiverRun International Film Festival.

Cresco Labs Announces First Quarter 2022 Results

Retrieved on: 
Wednesday, May 18, 2022

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (Cresco Labs or the Company), a vertically integrated, multi-state operator and the number one U.S. wholesaler of branded cannabis products, today released its financial results for the three months ended March 31, 2022.

Key Points: 
  • Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (Cresco Labs or the Company), a vertically integrated, multi-state operator and the number one U.S. wholesaler of branded cannabis products, today released its financial results for the three months ended March 31, 2022.
  • "Q1 was a solid quarter for the Cresco Labs team in a challenging environment for all consumer product categories.
  • We are pairing the best consumer brands with a broad, deep and strategic footprint, said Charles Bachtell, Co-Founder and CEO of Cresco Labs.
  • The compliance-focused foundation of both Cresco Labs and Columbia Care is helping ensure a smooth progression towards deal approval through a reasonable and manageable regulatory process.